KB, O., MP, P., JK, T., DR, B., WJ, O., RA, B., . . . DS, B. (2024). Fixed dose daptomycin: An opportunity for pharmacokinetic/pharmacodynamic optimization in Staphylococcus aureus infections. Pharmacotherapy, 44(8), 615. https://doi.org/10.1002/phar.4602
Chicago Style (17th ed.) CitationKB, Olney, et al. "Fixed Dose Daptomycin: An Opportunity for Pharmacokinetic/pharmacodynamic Optimization in Staphylococcus Aureus Infections." Pharmacotherapy 44, no. 8 (2024): 615. https://doi.org/10.1002/phar.4602.
MLA (9th ed.) CitationKB, Olney, et al. "Fixed Dose Daptomycin: An Opportunity for Pharmacokinetic/pharmacodynamic Optimization in Staphylococcus Aureus Infections." Pharmacotherapy, vol. 44, no. 8, 2024, p. 615, https://doi.org/10.1002/phar.4602.